Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554304 · ClinicalTrials.gov registry record · Phase 1
Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
A Phase 1 study, sponsored by Wockhardt.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT03554304: Completed Phase 1 study, sponsored by Wockhardt.
NCT03554304 is a Phase 1 study that has completed, run by Wockhardt. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03554304, a Phase 1 study, has completed, sponsored by Wockhardt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
Primary Outcome
as shown by analysis of the QT interval.
Interventions
- DRUG WCK 5222
- DRUG IV placebo matched to WCK 5222 / Moxifloxacin IV solution
- DRUG Moxifloxacin 400-mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-02-09 |
| Est. Completion | 2017-10-06 |
| Phase | Phase 1 |
What the finished NCT03554304 record still lists
NCT03554304 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which WCK 5222 is the first listed.
NCT03554304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03554304 about?
NCT03554304 is a clinical study titled "Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers". A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers
What is the current status of trial NCT03554304?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2017-02-09. Estimated completion is 2017-10-06.
What interventions are being tested in trial NCT03554304?
The interventions under investigation include: WCK 5222 (DRUG), IV placebo matched to WCK 5222 / Moxifloxacin IV solution (DRUG), Moxifloxacin 400-mg (DRUG).
Who is sponsoring clinical trial NCT03554304?
This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03554304's enrollment target sits among peer trials
60 831st of 2000 higher than 1,106 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI